Literature DB >> 28404651

Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.

Margareth Dalcolmo1,2, Regina Gayoso1,2, Giovanni Sotgiu3,2, Lia D'Ambrosio4,5,2, Jorge Luiz Rocha1, Liamar Borga1, Fatima Fandinho6, Jose Ueleres Braga7, Denise Arakaki Sanchez8, Fernanda Dockhorn8, Rosella Centis4, Giovanni Battista Migliori9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28404651     DOI： 10.1183/13993003.02309-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?

Authors:  Cynthia B E Chee; Kyi-Win KhinMar; Li-H Sng; Roland Jureen; Jeffery Cutter; Vernon J M Lee; Yee-Tang Wang
Journal:  Eur Respir J       Date:  2017-08-10       Impact factor: 16.671

Review 2.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

4.  Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.

Authors:  Zarir F Udwadia; Jeffrey A Tornheim; Shashank Ganatra; Andrea DeLuca; Camilla S Rodrigues; Amita Gupta
Journal:  BMC Infect Dis       Date:  2019-01-28       Impact factor: 3.090

5.  International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis.

Authors:  Giovanni Battista Migliori; Rosella Centis; Lia D'Ambrosio; Denise Rossato Silva; Adrian Rendon
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624

Review 6.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02

7.  Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil.

Authors:  Erivelton de Oliveira Sousa; Rita Terezinha de Oliveira Carneiro; Fátima Cristina Onofre Fandinho Montes; Emilyn Costa Conceição; Patricia Bartholomay; Jamocyr Moura Marinho; Karla Valéria Batista Lima; Marcio Santos da Natividade; Wildo Navegantes de Araújo; Eliana Dias Matos; Theolis Barbosa
Journal:  Rev Soc Bras Med Trop       Date:  2022-07-25       Impact factor: 2.141
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.